Literature DB >> 23238965

Dynamic characteristics of MR diffusion-weighted imaging in a rabbit liver VX-2 tumor model.

You-Hong Yuan1, En-Hua Xiao, Zhong He, Ke Jin, Cong Ma, Jun Xiang, Jian-Hua Xiao, Wei-Jian Chen.   

Abstract

PURPOSE: To investigate prospectively dynamic characteristics of the apparent diffusion coefficient (ADC) on MR diffusion-weighted imaging (DWI) in a rabbit VX-2 tumor model.
MATERIALS AND METHODS: Forty New Zealand rabbits were included in the study, and 47 rabbit VX-2 tumor models were developed by direct and intrahepatic implantation after opening the abdominal cavities. DWI was carried out periodically and respectively on days 7, 14 and 21 after implantation. The VX-2 tumor samples were studied by pathology. The distinction of VX-2 tumors on DWI was assessed by their ADC values by analysis of variance (ANOVA) using SPSS12.0 software.
RESULTS: The ADC values (mean ± SD) × 10(-3) mm(2)/s of 47 VX-2 tumors in the peripheral and central areas were 2.18 ± 0.29, 1.96 ± 0.33, 1.80 ± 0.35, 2.20 ± 0.29, 2.05 ± 0.30 and 1.96 ± 0.48, respectively, on days 7, 14 and 21 after implantation. ADC values of 47 VX-2 tumors in the area of the tumor periphery, center and normal parenchyma were higher when the b-value was 100 s/mm(2) than those when the b-value was 300 s/mm(2) (F = 17.964, p < 0.001; F = 13.986, p < 0.001; F = 128.681, p < 0.001). ADC values in the area of normal liver parenchyma were higher than those in the area of the VX-2 tumor periphery and center when the b-value was 100 or 300 s/mm(2). ADCs of viable tumor cells in VX-2 tumors were lower on DWI than those in the area of normal liver parenchyma around the tumor, and ADCs of dead tumor cells in VX-2 tumors were unequal, including high, equal and low values, but they were higher than in the area of normal liver parenchyma around tumors after dead tumor cells had been liquefied or had become cystic.
CONCLUSION: ADC is correlated with the tumor histology and degree of malignancy, and DWI has potential value for dynamically monitoring tumors and evaluating the degree of malignancy and therapeutic effect.

Entities:  

Mesh:

Year:  2012        PMID: 23238965     DOI: 10.1007/s11604-012-0156-6

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  27 in total

1.  Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model.

Authors:  Josephina A Vossen; Manon Buijs; Jean-Francois H Geschwind; Eleni Liapi; Veronica Prieto Ventura; Kwang Hun Lee; David A Bluemke; Ihab R Kamel
Journal:  J Comput Assist Tomogr       Date:  2009 Jul-Aug       Impact factor: 1.826

2.  Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma.

Authors:  Kazuhiro Saito; Yoichi Araki; Jinho Park; Ryo Metoki; Hiroaki Katsuyama; Ryota Nishio; Dai Kakizaki; Fuminori Moriyasu; Koichi Tokuuye
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

3.  Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.

Authors:  Frank H Miller; Nancy Hammond; Aheed J Siddiqi; Sagar Shroff; Gaurav Khatri; Yi Wang; Laura B Merrick; Paul Nikolaidis
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

4.  Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?

Authors:  Young Kon Kim; Chong Soo Kim; Young Min Han; Young Hwan Lee
Journal:  Clin Radiol       Date:  2011-03-01       Impact factor: 2.350

5.  [Clinical study of transcatheter arterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma by magnetic resonance imaging and functional diffusion-weighted imaging].

Authors:  Yu-bao Liu; Chang-hong Liang; Qiu-shi Wang; Shu-fei Xie; Yuan-xin Yu; Zhong-lin Zhang; Zai-yi Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2010-11-09

6.  New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.

Authors:  Gilles Piana; Ludovic Trinquart; Nawel Meskine; Vincent Barrau; Bernard Van Beers; Valérie Vilgrain
Journal:  J Hepatol       Date:  2010-11-23       Impact factor: 25.083

7.  [Correlation between MR diffusion weighted imaging with malignant degree of rabbit liver VX2 tumor models].

Authors:  Jun-Ping Wang; Ren-Ju Bai; Hao-Ran Sun; Xin Zhao; Ya-Jun Li; Jing Yang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2009-08-18

8.  Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor.

Authors:  Suk Hee Heo; Yong Yeon Jeong; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Jae Hyuk Lee; Yang Seok Koh; Chol Kyoon Cho; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

9.  Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver.

Authors:  Byung Jae Youn; Jin Wook Chung; Kyu Ri Son; Hyo-Cheol Kim; Hwan Jun Jae; Jeong Min Lee; In Chan Song; In-One Kim; Jae Hyung Park
Journal:  Acad Radiol       Date:  2008-05       Impact factor: 3.173

10.  Characteristics of liver on magnetic resonance diffusion-weighted imaging: dynamic and image pathological investigation in rabbit liver VX-2 tumor model.

Authors:  You-Hong Yuan; En-Hua Xiao; Jian-Bin Liu; Zhong He; Ke Jin; Cong Ma; Jun Xiang; Jian-Hua Xiao; Wei-Jian Chen
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

View more
  1 in total

1.  Treatment Effect of a Vascular-Disrupting Agent Dynamically Monitored by DWI: An Animal Experimental Study.

Authors:  Danping Huang; Ruimeng Yang; Yong Zou; Hongmei Lin; Xiangdong Xu; Xinhua Wei; Hanzheng Chang; Liqiong Wu; Wenshuang Ding; Wenjie Tang; Xinqing Jiang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.